pharmaceuticals - Latest News, Analysis, Opinion

Companies & Markets Markets

''Equity shareholding of CDPQ in Piramal Enterprises will increase from 3.68 per cent to 8.99 per cent,'' the CCI said.

Vaccination For Delhi Belly May Soon Enter Market

Himani Chandna

The adult vaccine market in India is very small compared to the paediatric market, however, exact sales figures are not available

Implementation May Remain Biggest Challenge For National Health Policy

Himani Chandna

The draft proposals are well articulated but the challenge lies in the implementation of the policy, says Sujay Shetty, leader of pharmaceuticals and life sciences at consultancy PwC India

National Health Policy Suggests 1.5% Rise In Spending, Maximum Focus On Primary Care

C H Unnikrishnan

The biggest failure in India's public healthcare system has been the poor focus on providing primary healthcare

Foreign Firms Reluctant To Launch New Drugs In India, Says GIPC

Himani Chandna

The executive director of international intellectual property at GIPC is in India to talk about the simmering discontent over IPR infrastructure

Affordability At Cost Of Innovation?

Swadeep Srivastava

Stents and other cost issues in the context of affordability of healthcare in India assume importance as price control can also affect innovation

Pharma Sector Growth To Be Moderate: ICRA

According to rating agency ICRA, revenue from US during from 2011-15 period, rose at an average 33 per cent

Medical Tourism To Keep Pharma Industry In Good Health: Study

The pharmaceuticals market expanded at a CAGR of 17.46 per cent during 2005-16, from $6 billion in 2005 to $36.7 billion in 2016

ISCR Launches Causality Assessment Portal At Its 10th Annual Conference

Roy Varghese

The theme of the two-day conference was 'Clinical Research in India – Patients First & Research for Patients'

Dr Reddy's December Quarter Net Profit Falls 16 Per Cent

Sales in North America, Dr Reddy's largest market, fell 15 percent, while those in India were up 2.4 percent, the company said in a statement

Pfizer Posts Rs 60.5 Crore Net Profit In December Quarter

Revenue for the quarter ended December 31, 2016 was Rs 504 crore as compared to Rs 521 crore in the same period last year

Johnson & Johnson To Buy Actelion For $30 Billion

Offer worth $280 a share plus one share in new R&D company; New R&D company to develop Actelion experimental drugs

Biopharma: India's New Sunrise Sector

Amir Ullah Khan

India requires a dual focus on entrepreneurship and innovation, as well as removing the barriers to new investment and improving the overall climate for business

Setting The Tone And Tenor In Medical Excellence

Roy Varghese